Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma
Conditions
High-risk Melanoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Helsinki University Hospital, Helsinki, Finland
Contact: Principal Investigator (Micaela Hernberg)Kuopio University Hospital, Kuopio, Finland
Contact: Principal Investigator (Okko-Sakari Kääriäinen)Tampere University Hospital, Tampere, Finland
Contact: Principal Investigator (Tanja Skyttä)Turku University Hospital, Turku, Finland
Contact: Principal Investigator (Veera Sivonen)Ålesund Hospital, Ålesund, Norway
Contact: Principal Investigator (Torbjørg Standal Skåravik)Haukeland University Hospital, Bergen, Norway
Contact: Principal Investigator (Cornelia Schuster)Sorlandet Hospital, Kristiansand, Norway
Contact: Principal Investigator (Unn-Miriam Kasti)Akershus University Hospital, Oslo, Norway
Contact: Principal Investigator (Martin Ruppert)Oslo University Hospital, Oslo, Norway
Contact: Principal Investigator (Henrik Jespersen)Stavanger University Hospital, Stavanger, Norway
Contact: Principal Investigator (Israr Hussain)North Norway University Hospital, Tromsø, Norway
Contact: Principal Investigator (Anita Amundsen)Trondheim University Hospital, Trondheim, Norway
Contact: Principal Investigator (Jarle Karlsen)Eskilstuna Hospital, Eskilstuna, Sweden
Contact: Principal Investigator (Andreas Nearchaou)Falu Hospital, Falun, Sweden
Contact: Principal Investigator (Gustav Ullenhag)Gävle Hospital, Gävle, Sweden
Contact: Principal Investigator (Olga val Munos)Sahlgrenska University Hospital, Gothenburg, Sweden
Contact: Principal Investigator (Lars Ny)Ryhov Hospital, Jönköping, Sweden
Contact: Principal Investigator (Mikael Wallander)Kalmar Hospital, Kalmar, Sweden
Contact: Principal Investigator (Magnus Lagerlund)Karlstad Hospital, Karlstad, Sweden
Contact: Principal Investigator (Emelie Bengtsson)Linköping University Hospital, Linköping, Sweden
Contact: Principal Investigator (Sander Ellegård)Skåne University Hospital, Lund, Sweden
Contact: Principal Investigator (Ana Carneiro)Örebro University Hospital, Örebro, Sweden
Contact: Principal Investigator (Georgios Fountoukidis)Karolinska University Hospital, Stockholm, Sweden
Contact: Principal Investigator (Hildur Helgadottir)Sundsvall Hospital, Sundsvall, Sweden
Contact: Principal Investigator (Flygare Flygare)Växjö Hospital, Vaxjo, Sweden
Contact: Principal Investigator (Signe Carlson)Västmanland Hospital, Västerås, Sweden
Contact: Principal Investigator (Tania Nicolaescu)
Study leads
Gustav J Ullenhag, professor
Principal Investigator
Uppsala University Hospital